BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2011

Jul 8, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2011-07-01

Reporting Person: STAAB THOMAS R II (Senior Vice President and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-07-01	Common Stock	A	25000	—	Acquired	25000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-07-01	Stock Option (Right to Buy)	$3.78	A	200000	Acquired	2021-07-01	Common Stock (200000)	Direct

Footnotes

F1: Restricted stock award. Will vest on the first anniversary of the date of grant, subject to continued employment on such vesting date.

F2: Options become exercisable at a rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.